Intervention for Depressed Latina Mothers of Children With Asthma
MAADRE
2 other identifiers
interventional
114
2 countries
2
Brief Summary
This study is to develop and pilot test a new group-based intervention for depressed Latina mothers of children with asthma. The investigators ongoing work has identified that close to 50% of Latina mothers of children with asthma report significant symptoms of depression. The intervention will combine asthma education and cognitive-behavioral strategies (e.g., increasing the pleasant activities that you do to help your mood) to address symptoms of depression. The investigators hope to improve mothers' mood, their feelings of confidence that they can manage asthma, and children's level of asthma control. The project has two phases. In Phase 1, the investigators will develop the intervention by working on the treatment manual and then conducting focus groups with Latina mothers to get input on the intervention. The investigators expect 24 mothers at each of 2 sites (RI and PR) to participate in focus groups (8 mothers per group). The group will take approximately 1-1.5 hours. In Phase 2, the investigators will conduct a small pilot of the intervention at both sites with new participants. At each site, 4 groups (4 sessions each) will be run. Participants will have an equal chance of being placed in the new intervention condition (asthma education and mood management), or in a control condition that covers asthma education and general topics regarding child health and wellness (e.g., encouraging reading, reducing screen time, nutrition). Participants will participate in a baseline research session, in the 4 intervention group sessions, and then in two follow-up research sessions (one at end of treatment which is expected to occur two months after enrollment, and one at 4-months post-treatment). They will complete survey instruments that assess their own depressive symptoms, family demographic characteristics, access/barriers to health care, self-efficacy to manage asthma, social network support, and family climate, as well as their child's asthma symptom frequency. Children 7-12 are included only for the assessment of asthma symptoms and lung function, which occurs at baseline, end of treatment, and 4-month follow up for 2 weeks at each time point. Participation in Phase 2 is expected to take approximately 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Aug 2009
Typical duration for phase_2
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 8, 2010
CompletedFirst Posted
Study publicly available on registry
March 30, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedNovember 18, 2023
July 1, 2010
2.3 years
July 8, 2010
November 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Asthma Control
Changes in Asthma Control from baseline will be assessed using the ACT at End of Treatment and 4 months post treatment
2 months after baseline (end of treatment), 4 months post treatment
Secondary Outcomes (1)
Maternal Depression
2 months after baseline (end of treatment), 4 months post treatment
Study Arms (2)
MAADRE
EXPERIMENTALGroup-based intervention combining asthma education and cognitive behavioral treatment for depressive symptoms
MAAS
ACTIVE COMPARATORGroup-based treatment combining asthma education and general information regarding child health
Interventions
Eligibility Criteria
You may qualify if:
- Latina mothers with symptoms of depression and children with persistent asthma
- Ages 7-12 years old
You may not qualify if:
- serious suicidal risk
- significant psychopathology (psychosis)
- ethnicity other than Latino
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
University of Puerto Rico
Rio Piedras, Puerto Rico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth L McQuaid, PhD
Rhode Island Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 8, 2010
First Posted
March 30, 2011
Study Start
August 1, 2009
Primary Completion
December 1, 2011
Study Completion
December 1, 2012
Last Updated
November 18, 2023
Record last verified: 2010-07